erythromycin has been researched along with tacrolimus in 40 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 16 (40.00) | 18.2507 |
2000's | 11 (27.50) | 29.6817 |
2010's | 10 (25.00) | 24.3611 |
2020's | 3 (7.50) | 2.80 |
Authors | Studies |
---|---|
Beck, WT; Schuetz, EG; Schuetz, JD | 1 |
Hasegawa, T; Hui, CS; Kitaichi, K; Miyamoto, KI; Sakai, M; Takagi, K; Wang, L; Yokogawa, K | 1 |
Li, Y; Li, YH; Wang, YH; Yang, L; Yang, SL | 1 |
Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
Chen, X; Lin, X; Skolnik, S; Wang, J | 1 |
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Bauer, S; Brockmöller, J; Kewitz, H; Roots, I | 1 |
Alonso de Begona, J; Bailey, LL; Beierle, F; Gundry, SR; Kawauchi, M | 1 |
Collier, D; Shaeffer, MS; Sorrell, MF | 1 |
Laurent, A; Lhoëst, G; Maton, N; Verbeeck, RK | 1 |
Cakaloglu, Y; Devlin, J; Tredger, JM; Williams, R | 1 |
Fung, J; Hakala, T; Jensen, C; Jordan, M; Scantlebury, V; Shapiro, R; Starzl, T; Venkataramanan, R | 1 |
Debray, D; Furlan, V; Jacquemin, E; Perello, L; Taburet, AM | 1 |
Lhoëst, G; Maton, N; Verbeeck, R | 1 |
Akagawa, KS; Keicho, N; Kudoh, S; Yotsumoto, H | 1 |
Alessiani, M; Barbera, D; Costa, A; Crema, A; De Ponti, F; Drivas, E; Merli, M; Rademacher, J; Spada, M; Zanola, S | 1 |
Anandan, JV; Basha, M; Long, P; Padhi, ID | 1 |
Ito, K; Kawasaki, S; Koyama, T; Otoshi, T; Takami, K; Takizawa, H | 1 |
Chisuwa, H; Hashikura, Y; Ikegami, T; Iwasaki, K; Katsuyama, Y; Kawasaki, S; Nakazawa, Y; Terada, M | 1 |
Andres, A; Carreño, A; Cubas, A; Delgado, M; Dominguez-Gil, B; Herrero, JC; Latorre, A; Manzanares, C; Morales, E; Morales, JM; Moreno, M | 1 |
Aoki, Y; Kao, PN | 1 |
Hayakawa, A; Itaya, N; Kakegawa, T; Kobayashi, H; Saito, H | 1 |
Eagle, DA; Gian, V; Lauwers, GY; Manivel, JC; Mastin, S; Moreb, JS; Wingard, JR | 1 |
Bayés, B; de la Camara, J; Diaz-Couchod, P; Lauzurica, R; Loscos, J | 1 |
De Vos, M; Depoortere, I; Lefebvre, R; Peeters, TL; Schoonjans, R; Van Vlem, B; Vanholder, R | 1 |
Dalhoff, K; Kirkegaard, P; Rasmussen, A; Schmidt, LE | 1 |
Dobrić, I; Milavec-Puretić, V; Persić-Vojinović, S; Rados, J; Spoljar, S | 1 |
Fernandes, NF; Kihiczak, G; Lambert, WC; Rozdeba, PJ; Schwartz, RA | 1 |
Cholongitas, E; Ioannidou, D; Kokolakis, GP; Krüger-Krasagakis, S | 1 |
Hatanaka, M; Kanekura, T | 1 |
Chiang, LH; Lee, WC; Tsai, TC; Wu, TH | 1 |
Ramirez, J | 1 |
Fakih, A; Grozdev, I; Makhoul, R | 1 |
Cruz, RJ; Humar, A; Poloyac, K; Roberts, M; Stein, W | 1 |
4 review(s) available for erythromycin and tacrolimus
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Disseminated Hailey-Hailey disease treated with topical tacrolimus and oral erythromycin: Case report and review of the literature.
Topics: Administration, Oral; Administration, Topical; Drug Therapy, Combination; Erythromycin; Humans; Immunosuppressive Agents; Male; Middle Aged; Pemphigus, Benign Familial; Protein Synthesis Inhibitors; Tacrolimus | 2006 |
Pityriasis lichenoides et varioliformis acuta: a disease spectrum.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Aged; Aged, 80 and over; Child; Child, Preschool; Erythromycin; Histamine Antagonists; Humans; Middle Aged; Phototherapy; Pityriasis Lichenoides; Tacrolimus; Tetracycline; Young Adult | 2010 |
Childhood granulomatous periorificial dermatitis: case report and review of the literature.
Topics: Administration, Topical; Anti-Infective Agents; Biopsy; Child; Dermatitis, Perioral; Drug Therapy, Combination; Erythromycin; Face; Granuloma; Humans; Immunosuppressive Agents; Male; Metronidazole; Skin; Tacrolimus | 2020 |
1 trial(s) available for erythromycin and tacrolimus
Article | Year |
---|---|
Relationship between postoperative erythromycin breath test and early morbidity in liver transplant recipients.
Topics: Adult; Anti-Bacterial Agents; Aryl Hydrocarbon Hydroxylases; Breath Tests; Cyclosporine; Cytochrome P-450 CYP3A; Erythromycin; Female; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Kidney Diseases; Liver; Liver Transplantation; Male; Middle Aged; Oxidoreductases, N-Demethylating; Postoperative Complications; Predictive Value of Tests; Tacrolimus | 2003 |
35 other study(ies) available for erythromycin and tacrolimus
Article | Year |
---|---|
Modulators and substrates of P-glycoprotein and cytochrome P4503A coordinately up-regulate these proteins in human colon carcinoma cells.
Topics: Adenocarcinoma; ATP Binding Cassette Transporter, Subfamily B, Member 1; Base Sequence; Blotting, Northern; Cell Line; Clotrimazole; Colonic Neoplasms; Cytochrome P-450 CYP2E1; Cytochrome P-450 Enzyme System; Dexamethasone; DNA Primers; Doxorubicin; Gene Expression Regulation, Neoplastic; Humans; Midazolam; Mixed Function Oxygenases; Molecular Sequence Data; Multigene Family; Phenobarbital; Phenytoin; Polymerase Chain Reaction; Rifampin; Tumor Cells, Cultured; Verapamil | 1996 |
Reversal of anticancer drug resistance by macrolide antibiotics in vitro and in vivo.
Topics: Animals; Anti-Bacterial Agents; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Calcium Channel Blockers; Cell Membrane; Cell Survival; Cyclosporine; Drug Resistance, Neoplasm; Immunosuppressive Agents; Leukemia P388; Macrolides; Mice; Neoplasm Transplantation; Tumor Cells, Cultured; Verapamil; Vinblastine | 2000 |
Modeling K(m) values using electrotopological state: substrates for cytochrome P450 3A4-mediated metabolism.
Topics: Computational Biology; Cyclohexanols; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Molecular Structure; Principal Component Analysis; Pyrrolizidine Alkaloids; Quantitative Structure-Activity Relationship; Reproducibility of Results; Substrate Specificity; Venlafaxine Hydrochloride | 2005 |
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Attenuation of intestinal absorption by major efflux transporters: quantitative tools and strategies using a Caco-2 model.
Topics: Adenosine; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Sub-Family B Member 4; ATP-Binding Cassette Transporters; Biological Transport; Caco-2 Cells; Chromatography, Liquid; Dibenzocycloheptenes; Diketopiperazines; Drug Discovery; Heterocyclic Compounds, 4 or More Rings; Humans; Intestinal Absorption; Mass Spectrometry; Models, Biological; Neoplasm Proteins; Pharmaceutical Preparations; Predictive Value of Tests; Propionates; Quinolines; Substrate Specificity | 2011 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
The effect of the new immunosuppressive drug FK506 on the formation of secondary metabolites of cyclosporin A.
Topics: Biotransformation; Cyclosporine; Diltiazem; Erythromycin; Humans; Immunosuppressive Agents; In Vitro Techniques; Microsomes, Liver; Tacrolimus | 1992 |
Plasma level of FK 506 in newborn goats and infant baboons.
Topics: Animals; Animals, Newborn; Antibodies, Monoclonal; Ciprofloxacin; Drug Interactions; Erythromycin; Gentamicins; Goats; Heart Transplantation; Papio; Tacrolimus; Transplantation, Heterologous | 1991 |
Interaction between FK506 and erythromycin.
Topics: Adult; Drug Interactions; Erythromycin; Humans; Liver Cirrhosis; Liver Transplantation; Male; Tacrolimus | 1994 |
Isolation and identification of a FK-506 C36-C37 dihydrodiol from erythromycin-induced rabbit liver microsomes.
Topics: Animals; Chromatography, High Pressure Liquid; Erythromycin; Magnetic Resonance Spectroscopy; Male; Microsomes, Liver; Molecular Structure; Rabbits; Spectrometry, Mass, Fast Atom Bombardment; Tacrolimus | 1994 |
Importance of cytochrome P-450IIIA activity in determining dosage and blood levels of FK 506 and cyclosporine in liver transplant recipients.
Topics: Aryl Hydrocarbon Hydroxylases; Breath Tests; Cyclosporine; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Erythromycin; Female; Humans; Lidocaine; Liver Transplantation; Male; Oxidoreductases, N-Demethylating; Predictive Value of Tests; Regression Analysis; Tacrolimus | 1994 |
Interaction between tacrolimus and erythromycin.
Topics: Animals; Creatinine; Drug Interactions; Erythromycin; Humans; Kidney Transplantation; Male; Middle Aged; Potassium; Rats; Tacrolimus | 1994 |
Interactions between FK506 and rifampicin or erythromycin in pediatric liver recipients.
Topics: Amino Acid Metabolism, Inborn Errors; Biliary Atresia; Child; Child, Preschool; Contraindications; Drug Interactions; Erythromycin; Female; Hepatic Encephalopathy; Humans; Liver Transplantation; Male; Propionates; Rifampin; Tacrolimus | 1995 |
Isolation and identification by FAB mass spectrometry and NMR spectroscopy of a demethylated metabolite of FK506 from erythromycin-induced rabbit liver microsomes.
Topics: Animals; Dealkylation; Erythromycin; In Vitro Techniques; Magnetic Resonance Spectroscopy; Male; Microsomes, Liver; Rabbits; Spectrometry, Mass, Fast Atom Bombardment; Tacrolimus | 1993 |
Antilymphocytic activity of erythromycin distinct from that of FK506 or cyclosporin A.
Topics: Antigens; Cell Line; Concanavalin A; Cyclosporine; Drug Synergism; Erythromycin; Humans; Immunosuppressive Agents; Interleukin-2; Lymphocyte Activation; Lymphocytes; Motilin; Receptors, Interleukin-2; Tacrolimus; Tumor Cells, Cultured | 1993 |
Stimulatory effect of FK506 and erythromycin on pig intestinal motility.
Topics: Animals; Duodenum; Erythromycin; Female; Gastrointestinal Motility; Jejunum; Muscle, Smooth; Myoelectric Complex, Migrating; Reference Values; Swine; Tacrolimus | 1996 |
Interaction between tacrolimus and erythromycin.
Topics: Adult; Anti-Bacterial Agents; Drug Interactions; Erythromycin; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Pneumonia; Postoperative Complications; Tacrolimus | 1997 |
[Effects of various drugs on IL-8 production by eosinophils collected from patients with allergic inflammation].
Topics: Anti-Bacterial Agents; Asthma; Clarithromycin; Eosinophils; Erythromycin; Fosfomycin; Humans; Hypersensitivity; Immunosuppressive Agents; In Vitro Techniques; Interleukin-8; Josamycin; Tacrolimus | 1998 |
Relationship between in vivo FK506 clearance and in vitro 13-demethylation activity in living-related liver transplantation.
Topics: Adolescent; Adult; Child; Child, Preschool; Erythromycin; Female; Humans; In Vitro Techniques; Infant; Liver; Liver Transplantation; Living Donors; Male; Methylation; Microsomes, Liver; Middle Aged; Tacrolimus | 1998 |
Clinical management of tacrolimus drug interactions in renal transplant patients.
Topics: Adult; Aged; Antifungal Agents; Candidiasis; Drug Interactions; Erythromycin; Female; Humans; Immunosuppressive Agents; Ketoconazole; Kidney Transplantation; Male; Phenytoin; Postoperative Complications; Rifampin; Tacrolimus | 1999 |
Erythromycin inhibits transcriptional activation of NF-kappaB, but not NFAT, through calcineurin-independent signaling in T cells.
Topics: Anti-Bacterial Agents; Calcineurin; DNA-Binding Proteins; Down-Regulation; Erythromycin; Genes, Reporter; Humans; Immunosuppressive Agents; Jurkat Cells; Luciferases; NF-kappa B; NFATC Transcription Factors; Nuclear Proteins; Signal Transduction; T-Lymphocytes; Tacrolimus; Transcription Factors; Transcriptional Activation; Transfection | 1999 |
[Effect of rapamycin on cytoplasmic accumulation of hetero nuclear ribonucleoprotein C-like unwinding protein 2].
Topics: Animals; Anti-Bacterial Agents; Cells, Cultured; Cytoplasm; Erythromycin; Heterogeneous-Nuclear Ribonucleoproteins; Immunosuppressive Agents; Mice; NF-kappa B; Ribonucleoproteins; Roxithromycin; Sirolimus; Tacrolimus | 2001 |
Gastroparesis following bone marrow transplantation.
Topics: Adult; Antiemetics; Bone Marrow Transplantation; Case-Control Studies; Erythromycin; Female; Gastric Emptying; Gastrointestinal Agents; Gastroparesis; Humans; Immunosuppressive Agents; Male; Metoclopramide; Middle Aged; Retrospective Studies; Risk Factors; Tacrolimus; Tissue Donors; Transplantation Conditioning; Transplantation, Homologous | 2001 |
Tacrolimus-associated severe bilateral corneal ulcer after renal transplantation.
Topics: Administration, Topical; Corneal Ulcer; Drug Therapy, Combination; Erythromycin; Female; Functional Laterality; Humans; Immunosuppressive Agents; Kidney Transplantation; Lubrication; Middle Aged; Mycophenolic Acid; Tacrolimus | 2002 |
In vitro evaluation of motilin agonism by macrolide immunosuppressive drugs.
Topics: Animals; Carbachol; Cyclosporine; Duodenum; Electric Stimulation; Erythromycin; Immunosuppressive Agents; In Vitro Techniques; Kinetics; Male; Motilin; Muscle Contraction; Muscle, Smooth; Rabbits; Sirolimus; Tacrolimus | 2002 |
Guttate psoriasis occurring on varicella lesions.
Topics: Betamethasone; Chickenpox; Child, Preschool; Erythromycin; Humans; Male; Psoriasis; Tacrolimus; Treatment Outcome | 2010 |
Case of childhood granulomatous periorificial dermatitis.
Topics: Administration, Cutaneous; Administration, Oral; Biopsy; Child; Drug Therapy, Combination; Erythromycin; Facial Dermatoses; Humans; Male; Ointments; Skin; Tacrolimus; Treatment Outcome | 2018 |
Coadministration of Erythromycin to Increase Tacrolimus Concentrations in Liver Transplant Recipients.
Topics: Erythromycin; Female; Humans; Immunosuppressive Agents; Liver Transplantation; Male; Middle Aged; Retrospective Studies; Tacrolimus | 2019 |
Recurrent Facial Rash.
Topics: Administration, Cutaneous; Adult; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Deprescriptions; Dermatitis, Perioral; Erythromycin; Glucocorticoids; Humans; Metronidazole; Recurrence; Risk Factors; Tacrolimus; Triamcinolone | 2020 |
Safe Use of Erythromycin For Refractory Gastroparesis After Small Bowel Transplantation.
Topics: Cytochrome P-450 Enzyme System; Erythromycin; Female; Gastroparesis; Humans; Metoclopramide; Tacrolimus; Treatment Outcome | 2022 |